As drug abuse and drug related crimes continue to prevail, expert forensic analysis is fundamental to the justice process. Global diagnostic company Randox Laboratories has released a number of new products for drug testing in public and private laboratories worldwide. - February 06, 2011
The new liquid stable Haptoglobin kit from Randox provides a highly sensitive and specific method for the quantitative determination of Haptoglobin in human serum. The method is fully automated and suitable for use on the RX series of bench top clinical analysers including the RX daytona and RX imola. - January 20, 2011
The American Diabetes Association, International Diabetes Federation and European Association for the Study of Diabetes consider HbA1c a more reliable indicator of long term diabetic control than blood glucose. - August 04, 2010
The Predictive Safety Testing Consortium (PSTC) has provided data which supports the use of various renal markers, including Cystatin C, in a preclinical setting. The biomarkers have been shown to outperform traditional markers, such as creatinine and blood urea nitrogen (BUN), in both specificity and... - July 16, 2010
Randox Laboratories is one of the largest manufacturers of quality control sera in the world. The Acusera range of quality controls currently covers over 290 parameters and is set to expand with the introduction of several new quality controls.
Quality control from Randox guarantees outstanding performance... - June 25, 2010
The new and improved Lithium kit from Randox is intended for the quantitative in vitro determination of Lithium in serum and is suitable for use on a wide range of clinical analysers. - May 27, 2010
Maternal serum screening is widely used to evaluate the risk of certain serious birth defects such as Down’s syndrome and Spina Bifida. - March 28, 2010
RANDOX Laboratories (“Randox”) will represent Northern Ireland when it heads to the House of Lords later this month to compete in the UK-wide 2010 International Trade Awards sponsored by HSBC.
The Antrim-based independent medical diagnostics company beat off stiff local competition to win... - March 12, 2010
Randox has developed an innovative multi-marker drugs of abuse testing procedure for rapid drug screening programmes. The Drugs of Abuse (DoA) biochips permit the analysis of up to 10 drug classes from a single patient sample providing rapid and accurate testing.
Randox biochip array technology is based... - November 26, 2009
RANDOX Laboratories (“Randox”), the Antrim-based independent global diagnostics company, will today unveil a revolutionary new cardiac machine at the world’s largest medical trade fair being held this week in Dusseldorf, Germany. - November 21, 2009
Randox have further expanded their assay portfolio with the launch of a new highly accurate Aldolase test aimed at diagnosing patients who have muscle or liver damage.
Aldolase is an enzyme that helps convert glucose into energy and is found throughout the body but is primarily found in high levels... - October 29, 2009
The Institute of Mechanical Engineers has awarded Randox Laboratories the Award for Product Innovation at the Manufacturing Excellence Awards held on 25th June 2009 in London.
The Manufacturing Excellence Awards are an annual event that recognises the very best in the UK manufacturing industry and rewards... - October 17, 2009
Randox announce a significant improvement in liquid CO2 measurement, with improved reagent stability for on board use, calibration and shelf life on the RX Series clinical chemistry analysers.
Carbon dioxide (CO2) is a metabolic waste product of cellular respiration. Elevated levels of CO2 in the blood... - October 17, 2009
Randox have launched Drugs of Abuse (DoA) reagents for use on the RX Series of Clinical Chemistry Analysers. You can now detect 10 drugs of abuse in human urine on quality systems offering time, labour and cost savings.
Drug abuse is a serious problem worldwide and its prevalence is increasing year... - October 17, 2009
Randox Laboratories have launched a revolutionary new Biochip Analyser that will save cardiac patients lives by providing immediate diagnosis at the point of care.
Cardiovascular disease is a progressive and complicated condition, covering a spectrum of symptoms and biochemical processes which are different... - October 14, 2009
Randox have developed three biochip arrays for the detection of a variety of antimicrobial agents. These arrays enable simultaneous multi-analyte testing of up to 12 antimicrobials from a single sample. Antimicrobial Array I tests for sulphonamides, Array II for general antibiotics and Array III for... - October 14, 2009